SOURCE: CLX Investment Company, Inc.

January 18, 2008 10:02 ET

CLX Investment Company Director Files Form 4 on Common Stock Acquisitions Totaling Over 11 Million Shares

MURRIETA, CA--(Marketwire - January 18, 2008) - CLX Investment Company, Inc. (OTCBB: CLXN), which owns 51% of Zonda, Incorporated, a developer and manufacturer of unique diagnostic tests for the medical and non-medical markets, today announced that Pat Edgerton, a member of the company's Board of Directors, has filed a Form 4 Statement of Change in Beneficial Ownership of Securities with the Securities and Exchange Commission regarding the acquisition of CLX common stock.

The Form 4 reported two stock acquisition transactions for Mr. Edgerton, the first for 10 million shares at a price of $.01 on August 29, 2007 and the second for 1.125 million shares at a price of $0.008 on December 7, 2007. As a result of acquiring these shares, the Form 4 reports that Mr. Edgerton now holds 13,791,666 shares of CLX common stock.

"I am pleased to add to my common stock position at this stage of the company's development, especially as we prepare for the initiation of clinical trials for Zonda's rapid point of care test for Chlamydia," stated Mr. Edgerton.

CLX anticipates a mid- to late-first calendar quarter 2008 beginning for the clinical trials.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit http://www.clxinvestments.com/email.php.

About CLX Investment Company

CLX Investment Company (www.clxinvestments.com) holds a 51% equity interest in Zonda, Inc. CLX has also invested, and holds a common stock position, in ActionView International, Inc. (www.actionviewinternational.com), a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    951-677-8073
    Email Contact